GMAB — GENMAB A/S
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 303 SEC-registered investment managers reported holding GMAB (GENMAB A/S) in their latest 13F filings, with a combined reported value of $2.70B across 98.40M shares. That is +17.5% by share count (+14.41M shares) versus the previous quarter, while reported value moved +17.8%. Ownership is concentrated: the five largest holders account for 45.6% of reported value and the top ten for 64.8%.
Compared with the prior quarter, 50 opened new positions, 100 added to existing stakes, 103 trimmed, 33 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of GENMAB A/S (GMAB) include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, ALLIANCEBERNSTEIN L.P., ranked by reported 13F value among the 579 institutional holders on this page.
GMAB is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 258 | 40.11M | $1.46B | +2.3% |
| Q2 2026 | 303 | 98.40M | $2.70B | +17.5% |
| Q1 2026 | 285 | 82.93M | $2.27B | +8.3% |
| Q4 2025 | 298 | 71.90M | $2.22B | +15.0% |
| Q3 2025 | 251 | 60.46M | $1.91B | -2.2% |
| Q2 2025 | 210 | 57.60M | $1.20B | -2.2% |
| Q1 2025 | 213 | 58.57M | $1.16B | +14.7% |
| Q4 2024 | 222 | 55.69M | $1.17B | +7.2% |
Over the 8 quarters shown, institutional share counts decreased 28% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+17.5%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.07M | $216.52M | 0.09% | Add | |
| 6.06M | $216.09M | 0.01% | Add | |
| 3.90M | $139.16M | 0.02% | New | |
| 3.23M | $115.07M | 0.07% | Add | |
| 1.50M | $82.55M | 0.02% | Add | |
| 2.27M | $81.07M | 0.11% | Reduce | |
| 1.72M | $61.19M | 0.00% | Add | |
| 1.24M | $44.22M | 0.06% | Reduce | |
| 1.22M | $43.52M | 0.07% | Add | |
| 1.15M | $41.04M | 0.04% | Add | |
| 876.65K | $31.27M | 0.03% | Reduce | |
| 771.45K | $27.52M | 0.00% | Add | |
| 718.18K | $25.62M | 0.39% | Reduce | |
| 630.80K | $22.50M | 0.01% | Reduce | |
| 627.83K | $22.33M | 0.00% | Reduce | |
| 576.35K | $20.56M | 0.01% | Reduce | |
| 510.75K | $18.22M | 0.05% | Reduce | |
| 426.93K | $15.23M | 0.03% | Reduce | |
| 419.37K | $14.96M | 0.02% | Add | |
| 407.00K | $14.52M | 0.46% | Reduce | |
| 389.67K | $13.90M | 0.15% | Reduce | |
| 382.68K | $13.65M | 0.02% | Add | |
| 255.59K | $9.12M | 0.30% | Add | |
| 250.89K | $8.95M | 0.01% | Add | |
| 226.10K | $8.07M | 2.12% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 13.13M | $360.77M | 6.75% | Add | |
| 11.37M | $312.28M | 1.07% | Reduce | |
| 8.64M | $231.94M | 0.08% | Reduce | |
| 6.87M | $188.58M | 2.36% | Add | |
| 4.98M | $136.67M | 0.06% | Hold | |
| 4.67M | $128.32M | 0.00% | Add | |
| 4.05M | $111.12M | 5.92% | Add | |
| 3.52M | $96.64M | 0.13% | Reduce | |
| 3.51M | $96.33M | 0.15% | Add | |
| 3.09M | $86.90M | 0.82% | Reduce | |
| 3.00M | $82.41M | 1.23% | Reduce | |
| 2.76M | $75.72M | 0.04% | Add | |
| 1.69M | $46.40M | 0.09% | Add | |
| 1.63M | $44.78M | 0.00% | Reduce | |
| 1.45M | $39.81M | 0.06% | Add | |
| 1.28M | $35.14M | 0.01% | Add | |
| 1.20M | $33.04M | 0.01% | Add | |
| 1.07M | $29.28M | 0.03% | Reduce | |
| 961.05K | $26.40M | 0.01% | Add | |
| 919.05K | $25.25M | 0.36% | Add | |
| 916.60K | $25.18M | 0.00% | Reduce | |
| 910.60K | $25.01M | 0.01% | Add | |
| 910.60K | $25.01M | 0.03% | Add | |
| 883.43K | $24.27M | 0.02% | Add | |
| 829.69K | $22.79M | 0.01% | Reduce |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.93M | $346.79M | 1.46% | Reduce | |
| 9.56M | $294.36M | 0.10% | Reduce | |
| 7.97M | $213.78M | 4.37% | Add | |
| 4.98M | $133.49M | 0.07% | Hold | |
| 4.54M | $121.72M | 0.00% | Reduce | |
| 4.41M | $118.44M | 0.18% | Add | |
| 3.66M | $98.28M | 1.60% | New | |
| 3.23M | $86.70M | 0.89% | Reduce | |
| 2.46M | $66.06M | 0.87% | New | |
| 2.46M | $66.04M | 0.05% | Add | |
| 2.34M | $62.77M | 0.10% | Add | |
| 2.18M | $58.62M | 0.00% | Add | |
| 1.25M | $33.58M | 0.06% | Add | |
| 1.19M | $32.01M | 0.01% | Add | |
| 1.08M | $28.91M | 0.03% | Reduce | |
| 1.01M | $27.14M | 0.00% | Reduce | |
| 950.53K | $25.50M | 0.00% | Reduce | |
| 931.26K | $24.99M | 0.01% | Reduce | |
| 862.30K | $23.14M | 0.01% | Add | |
| 797.07K | $21.39M | 0.02% | Add | |
| 792.29K | $21.26M | 0.01% | Add | |
| 792.29K | $21.26M | 0.03% | Add | |
| 758.50K | $20.35M | 0.31% | Reduce | |
| 752.26K | $20.18M | 0.85% | New | |
| 677.35K | $18.17M | 0.04% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.42M | $444.09M | 1.86% | Add | |
| 10.88M | $335.01M | 0.11% | Reduce | |
| 7.04M | $216.83M | 5.53% | Add | |
| 4.98M | $153.32M | 0.09% | Add | |
| 4.59M | $141.49M | 0.00% | Add | |
| 3.49M | $107.58M | 0.17% | Add | |
| 3.37M | $103.85M | 0.91% | Reduce | |
| 1.83M | $56.50M | 0.00% | Add | |
| 1.34M | $41.13M | 0.03% | Reduce | |
| 1.33M | $41.07M | 0.02% | Add | |
| 1.10M | $33.84M | 0.04% | New | |
| 1.06M | $32.57M | 0.00% | Reduce | |
| 957.03K | $29.48M | 0.00% | Add | |
| 895.84K | $27.59M | 0.06% | Reduce | |
| 827.22K | $25.48M | 0.37% | New | |
| 806.63K | $24.84M | 0.01% | Hold | |
| 710.59K | $21.89M | 0.02% | Reduce | |
| 679.38K | $20.92M | 0.04% | Add | |
| 506.66K | $15.61M | 0.04% | New | |
| 438.02K | $13.49M | 0.01% | Add | |
| 431.55K | $13.29M | 0.01% | Add | |
| 379.36K | $11.68M | 0.04% | New | |
| 369.19K | $11.37M | 0.04% | Reduce | |
| 367.28K | $11.31M | 0.04% | Add | |
| 364.76K | $11.23M | 0.14% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.08M | $339.76M | 1.46% | Add | |
| 10.95M | $335.96M | 0.11% | Add | |
| 3.82M | $117.06M | 3.91% | New | |
| 3.64M | $111.74M | 0.07% | Add | |
| 3.48M | $106.86M | 0.78% | Add | |
| 3.45M | $105.83M | 0.00% | Add | |
| 2.82M | $86.54M | 0.11% | Add | |
| 175.00K | $53.02M | 8.51% | New | |
| 1.69M | $51.75M | 0.04% | Reduce | |
| 1.67M | $51.36M | 0.00% | Reduce | |
| 1.43M | $43.94M | 0.09% | Reduce | |
| 1.39M | $42.67M | 0.09% | Reduce | |
| 1.12M | $34.34M | 0.00% | Add | |
| 1.12M | $34.31M | 0.01% | Add | |
| 882.30K | $27.06M | 0.00% | Add | |
| 822.74K | $25.23M | 0.03% | Reduce | |
| 809.94K | $24.84M | 0.01% | Add | |
| 533.21K | $16.35M | 0.03% | Reduce | |
| 481.27K | $14.76M | 0.41% | New | |
| 459.18K | $14.08M | 0.07% | Reduce | |
| 422.94K | $12.97M | 0.02% | New | |
| 372.05K | $11.41M | 0.01% | Add | |
| 371.26K | $11.39M | 0.01% | Add | |
| 328.09K | $10.06M | 0.00% | Reduce | |
| 315.86K | $9.69M | 0.11% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.66M | $220.28M | 0.07% | Reduce | |
| 7.92M | $163.64M | 0.80% | Add | |
| 3.45M | $71.37M | 0.05% | Add | |
| 3.17M | $65.41M | 0.00% | Reduce | |
| 2.92M | $60.42M | 0.41% | Add | |
| 2.77M | $57.16M | 0.08% | Add | |
| 2.70M | $55.72M | 0.00% | Reduce | |
| 1.91M | $39.40M | 0.06% | Reduce | |
| 1.82M | $37.62M | 0.08% | Reduce | |
| 1.77M | $36.57M | 0.03% | Add | |
| 1.62M | $33.44M | 0.06% | Reduce | |
| 949.18K | $19.61M | 0.07% | Reduce | |
| 934.07K | $19.30M | 0.03% | Reduce | |
| 933.31K | $19.28M | 0.00% | Add | |
| 889.27K | $18.37M | 0.01% | Add | |
| 803.60K | $16.60M | 0.00% | Add | |
| 749.60K | $15.49M | 0.01% | Add | |
| 680.53K | $14.06M | 0.00% | Add | |
| 650.00K | $13.43M | 2.69% | Add | |
| 567.79K | $11.73M | 0.00% | Reduce | |
| 538.50K | $11.13M | 0.06% | Reduce | |
| 493.51K | $10.20M | 0.05% | New | |
| 484.87K | $10.02M | 0.01% | Reduce | |
| 48.01K | $9.93M | 1.41% | Reduce | |
| 447.06K | $9.24M | 1.05% | New |
New Positions (Q2 2026)
- Dixon Mitchell Investment Counsel Inc. 416.00K sh · $11.43M
- Caption Management, LLC 199.77K sh · $5.49M
- Balyasny Asset Management 141.10K sh · $3.88M
- Sixth Street Partners Management Company, L.P. 139.12K sh · $3.82M
- Point72 Asset Management 135.65K sh · $3.73M
- Woodline Partners LP 133.39K sh · $3.66M
- GEODE CAPITAL MANAGEMENT, LLC 65.71K sh · $1.81M
- Entropy Technologies, LP 48.65K sh · $1.34M
- ExodusPoint Capital Management, LP 43.17K sh · $1.19M
- Nuveen, LLC 42.95K sh · $1.18M
- GTS SECURITIES LLC 32.12K sh · $882.23K
- LMR Partners LLP 25.00K sh · $686.75K
Fully Exited (vs previous quarter)
- Dorsey Wright & Associates sold 64.39K sh · $1.73M
- Advisors Preferred, LLC sold 50.72K sh · $1.36M
- DIVERSIFY WEALTH MANAGEMENT, LLC sold 46.56K sh · $1.22M
- Y-Intercept (Hong Kong) Ltd sold 44.67K sh · $1.20M
- BOOTHBAY FUND MANAGEMENT, LLC sold 40.05K sh · $1.07M
- Brooklyn Investment Group sold 35.82K sh · $961.12K
- AdvisorShares Investments LLC sold 30.85K sh · $827.79K
- VIRTUS ADVISERS, LLC sold 30.83K sh · $827.17K
- BankChampaign, National Association sold 25.62K sh · $687.44K
- AXQ CAPITAL, LP sold 21.78K sh · $584.28K
- Arrowpoint Investment Partners (Singapore) Pte. Ltd. sold 16.03K sh · $430.08K
- HighTower Advisors, LLC sold 15.43K sh · $414.07K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arrowstreet Capital | 6.07M | 4.98M | 4.98M | 4.98M | 3.64M | 3.45M | 1.37M | 30.44K | 93.63K | 37.41K | — | — | — | — | 1.01M | 1.76M | 1.49M | 1.29M | 869.22K | 530.32K |
| BlackRock Inc | 6.06M | 4.67M | 4.54M | 4.59M | 3.45M | 3.17M | 3.52M | 4.20M | 4.62M | — | — | — | — | — | — | — | — | — | — | — |
| Capital World Investors | 3.90M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| FIRST TRUST ADVISORS LP | 3.23M | 2.76M | 2.46M | 1.34M | 1.69M | 1.77M | 1.71M | 1.64M | 1.39M | 1.21M | 1.23M | 1.27M | 1.09M | — | — | — | — | — | — | — |
| Franklin Resources | 1.50M | 1.20M | 1.19M | 30.65K | 31.34K | 30.15K | 31.21K | 30.90K | 25.66K | 27.07K | 30.65K | 30.35K | 557.61K | 645.64K | 534.19K | 441.36K | 9.60K | 9.77K | 6.43K | 6.85K |
| Renaissance Technologies | 2.27M | 3.52M | 4.41M | 3.49M | 2.82M | 2.77M | 2.26M | 1.93M | 1.79M | 1.46M | 1.36M | 1.49M | 1.17M | 839.10K | 1.05M | 1.19M | 916.40K | 980.20K | 1.09M | 1.07M |
| Morgan Stanley | 1.72M | 1.63M | 2.18M | 1.83M | 1.67M | 2.70M | 2.84M | 2.81M | 1.64M | 1.03M | 974.04K | 1.09M | 1.10M | 1.01M | 1.08M | 1.22M | 868.04K | 728.50K | 105.60K | 142.83K |
| FEDERATED HERMES, INC. | 1.24M | 1.45M | 1.25M | 679.38K | 422.94K | — | — | — | — | — | — | — | 4.69K | — | — | — | — | — | — | — |
| Marshall Wace | 1.22M | 829.66K | 15.00K | 358.44K | 533.21K | 1.91M | 2.18M | 1.12M | 428.05K | 648.38K | 949.42K | 215.41K | 210.80K | — | — | 8.26K | — | — | — | — |
| Pictet Asset Management Holding SA | 1.15M | 1.07M | 1.08M | 1.10M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Russell Investments Group, Ltd. | 876.65K | 883.43K | 797.07K | 710.59K | 822.74K | 934.07K | 1.08M | 510.78K | 2.68K | 1.75K | 939 | 395 | 1.73K | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 771.45K | 764.69K | 1.01M | 1.06M | 1.12M | 680.53K | 484.85K | 540.55K | 278.19K | 245.12K | 374.41K | 267.50K | 422.44K | 397.50K | 391.41K | 451.66K | 437.00K | 245.93K | 220.61K | 153.35K |
| Perpetual Ltd | 718.18K | 919.05K | 758.50K | 827.22K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 630.80K | 961.05K | 298.13K | 184.19K | 82.17K | 484.87K | 541.00K | 1.44M | 60.45K | 62.41K | 49.70K | 47.36K | 48.66K | 72.62K | 65.20K | 56.95K | 37.61K | 42.93K | 68.33K | 65.27K |
| JPMorgan Chase & Co | 627.83K | 744.82K | 222.61K | 228.49K | 118.18K | 933.31K | 797.50K | 407.61K | 12.94K | 27.51K | 31.88K | 135.90K | 175.99K | 123.47K | 166.75K | 199.29K | 179.75K | 173.39K | 135.12K | 94.67K |
| AMERICAN CENTURY COMPANIES INC | 576.35K | 599.95K | 538.94K | 431.55K | 372.05K | 308.44K | 383.89K | 320.57K | 397.08K | 452.19K | 464.94K | 456.42K | 450.51K | — | — | — | — | — | — | — |
| CIBC WORLD MARKET INC. | 510.75K | 514.76K | 488.27K | 367.28K | 279.93K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 426.93K | 1.69M | 677.35K | 39.45K | — | — | 111.16K | 236.84K | 313.55K | 114.52K | 237.96K | 257.12K | 130.01K | — | — | — | — | — | — | — |
| Quantinno Capital Management LP | 419.37K | 333.39K | 282.50K | 246.91K | 209.84K | 158.13K | 95.91K | 90.33K | 24.21K | 15.44K | 23.70K | 44.59K | 16.55K | — | — | — | — | — | — | — |
| Dixon Mitchell Investment Counsel Inc. | 407.00K | 416.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold GMAB?
As of 2026-Q2, 303 institutional funds reported holding GMAB (GENMAB A/S) in SEC 13F filings, with a combined reported value of $2.70B.
How many shares of GMAB do institutions own?
13F filers reported 98.40M shares of GMAB, worth $2.70B in aggregate at the end of 2026-Q2.
Is institutional ownership of GMAB rising or falling?
Share counts moved +17.5% versus the prior quarter — accumulation.
Who are the top institutional holders of GMAB?
The largest 13F holders are Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, ALLIANCEBERNSTEIN L.P., Arrowstreet Capital, BlackRock Inc; the top 25 are ranked at the top of this page.
Who are the major shareholders of GENMAB A/S?
The major shareholders of GENMAB A/S (GMAB) by reported 13F value are Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, ALLIANCEBERNSTEIN L.P., Arrowstreet Capital, BlackRock Inc, among 579 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.